Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Immunoprecise Antibodies Ltd (IPA.VN)

Immunoprecise Antibodies Ltd (IPA.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Immunoprecise Antibodies Ltd 3204 - 4464 Markham Street Victoria BC V8Z 7X8 CAN

https://www.immunoprecise.com P: 701-404-1043

Description:

ImmunoPrecise Antibodies Ltd is a supplier of custom antibodies to the research industry and industrial community. The company has aggregated its operations into one reportable segment, Antibody Production, and Related Services. It operates in three principal geographical areas - the United States of America, Canada, Europe, and others. The majority of its revenue is derived from Europe.

Key Statistics

Overview:

Market Capitalization, $K 162,080
Shares Outstanding, K 24,935
Annual Sales, $ 20,665 K
Annual Net Income, $ -26,560 K
Last Quarter Sales, $ 6,221 K
Last Quarter Net Income, $ -2,940 K
60-Month Beta 0.09
% of Institutional Shareholders 0.16%

Growth:

1-Year Return -12.87%
3-Year Return 103.13%
5-Year Return 160.00%
5-Year Revenue Growth 30.59%

Per-Share Information:

Latest Earnings Date 12/12/22
Earnings Per Share ttm -1.06
Dividend Payout Ratio 0.00%
Most Recent Split 1-5 on 11/23/20

IPA.VN Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -25.72%
Return-on-Assets % -17.70%
Profit Margin % 0.00%
Debt/Equity N/A
Price/Sales 7.04
Price/Book 2.45
Book Value/Share 2.66
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar